Sherafatmanesh S, Madadizadeh F, Hosseinzadeh M, Mohammadi M, Mirzaei M, Khosravi-Boroujeni H
J Diabetes Metab Disord. 2024; 23(2):2263-2277.
PMID: 39610544
PMC: 11599531.
DOI: 10.1007/s40200-024-01494-4.
Tsai W, Kim J, Yeung N, Lu Q
Asian Am J Psychol. 2024; 15(3):213-222.
PMID: 39430036
PMC: 11487620.
DOI: 10.1037/aap0000330.
Zheng Y, Sun S, Yu W, Xu L, Liu R, Chu C
BMC Neurol. 2024; 24(1):388.
PMID: 39402438
PMC: 11472521.
DOI: 10.1186/s12883-024-03895-7.
Younes A, Point C, Wacquier B, Lanquart J, Hein M
Diagnostics (Basel). 2024; 14(17).
PMID: 39272639
PMC: 11394253.
DOI: 10.3390/diagnostics14171854.
Shi J, Zhang Z, Zhang J, Zhang Y, Qiu J, Liu F
Chin Med J (Engl). 2024; .
PMID: 39164815
PMC: 11407812.
DOI: 10.1097/CM9.0000000000003202.
Psychiatric Characteristics, Symptoms of Insomnia and Depression, Emotion Regulation, and Social Activity among Swiss Medical Students.
Regli J, Sadeghi-Bahmani D, Rigotti V, Stanga Z, Ulgur I, Fichter C
J Clin Med. 2024; 13(15).
PMID: 39124639
PMC: 11313248.
DOI: 10.3390/jcm13154372.
Impact of trazodone once-a-day on quality of life and functional recovery in adults with major depressive disorder: A prospective, observational study.
Tellone V, Markovic O, Strashimirova M, Sani G, Lenderking W, Margolis M
Brain Behav. 2024; 14(7):e3580.
PMID: 39034363
PMC: 11260556.
DOI: 10.1002/brb3.3580.
Persistently short or long sleep duration increases the risk of sensory impairment in Chinese older adults.
Yang L, Du J, Duan Y, Cui Y, Qi Q, Liu Z
Front Public Health. 2024; 12:1329134.
PMID: 38487190
PMC: 10937584.
DOI: 10.3389/fpubh.2024.1329134.
The Relationship of Early Sleep Improvement With Response to Pharmacotherapy in Unipolar Psychotic Depression.
Vos C, Birkenhager T, Nolen W, Van den Broek W, Ter Hark S, Schellekens A
J Clin Psychopharmacol. 2023; 43(6):486-492.
PMID: 37930199
PMC: 10662627.
DOI: 10.1097/JCP.0000000000001756.
The burden of untreated insomnia disorder in a sample of 1 million adults: a cohort study.
Grandner M, Olivieri A, Ahuja A, Busser A, Freidank M, McCall W
BMC Public Health. 2023; 23(1):1481.
PMID: 37537544
PMC: 10399052.
DOI: 10.1186/s12889-023-16329-9.
Daytime Sleepiness Is Associated with Lower Cognitive Scores: The Look AHEAD Study.
Hayden K, Anderson A, Spira A, St-Onge M, Ding J, Culkin M
JAR Life. 2023; 12:46-55.
PMID: 37457508
PMC: 10345450.
DOI: 10.14283/jarlife.2023.9.
Evaluation of Sleep Quality and Fatigue in Patients with Usher Syndrome Type 2a.
Hendricks J, Metz J, Velde H, Weeda J, Hartgers F, Yzer S
Ophthalmol Sci. 2023; 3(4):100323.
PMID: 37334034
PMC: 10272497.
DOI: 10.1016/j.xops.2023.100323.
Long-Term Treatment with Trazodone Once-A-Day (TzOAD) in Patients with MDD: An Observational, Prospective Study.
Shrashimirova M, Tyanev I, Cubala W, Wichniak A, Vodickova-Borzova C, Ruggieri A
Neuropsychiatr Dis Treat. 2023; 19:1181-1193.
PMID: 37201102
PMC: 10187683.
DOI: 10.2147/NDT.S399948.
Sleep Pattern Is Related to Mental Health among Chinese Collegiate Student Athletes.
Wei W, Liu W
Int J Environ Res Public Health. 2022; 19(15).
PMID: 35897332
PMC: 9329793.
DOI: 10.3390/ijerph19158961.
Assessing the depression risk in the U.S. adults using nomogram.
Zhang Y, Tian W, Han X, Yan G, Ma Y, Huo S
BMC Public Health. 2022; 22(1):416.
PMID: 35232400
PMC: 8889727.
DOI: 10.1186/s12889-022-12798-6.
G-protein coupled receptors and synaptic plasticity in sleep deprivation.
Parmar S, Tadavarty R, Sastry B
World J Psychiatry. 2021; 11(11):954-980.
PMID: 34888167
PMC: 8613756.
DOI: 10.5498/wjp.v11.i11.954.
Risk of Excessive Daytime Sleepiness Associated to Major Depression in Adolescents.
Boz S, Lanquart J, Mungo A, Delhaye M, Loas G, Hein M
Psychiatr Q. 2021; 92(4):1473-1488.
PMID: 33956300
DOI: 10.1007/s11126-021-09922-x.
Maternal insomnia during the COVID-19 pandemic: associations with depression and anxiety.
Wang J, Zhou Y, Qian W, Zhou Y, Han R, Liu Z
Soc Psychiatry Psychiatr Epidemiol. 2021; 56(8):1477-1485.
PMID: 33891160
PMC: 8063170.
DOI: 10.1007/s00127-021-02072-2.
Spotlight on Pimavanserin Tartrate and Its Therapeutic Potential in the Treatment of Major Depressive Disorder: The Evidence to Date.
Soogrim V, Ruberto V, Murrough J, Jha M
Drug Des Devel Ther. 2021; 15:151-157.
PMID: 33469267
PMC: 7812044.
DOI: 10.2147/DDDT.S240862.
Population Pharmacokinetics and Exposure-Response Analyses for the Most Frequent Adverse Events Following Treatment With Lemborexant, an Orexin Receptor Antagonist, in Subjects With Insomnia Disorder.
Lalovic B, Majid O, Aluri J, Landry I, Moline M, Hussein Z
J Clin Pharmacol. 2020; 60(12):1642-1654.
PMID: 32666570
PMC: 7689791.
DOI: 10.1002/jcph.1683.